精神疾病胺治疗后的泌尿系统症状:一个系统的审查
Jess Kerr-Gaffney1, Anna Tröger1,2, Alice Caulfield1
1Department of Psychological Medicine, Centre for Affective Disorders, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
Journal of psychopharmacology (Oxford, England)
|June 30, 2025
概括
胺对精神疾病有前途,但存在有关尿道毒性的担忧. 目前的证据表明,胺治疗与尿路症状的增加无关,尽管需要更多的长期研究.
科学领域:
- 精神病学是一个精神病学.
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 药理学 药理学是指药理学的学科.
背景情况:
- 胺是一种快速起作用的治疗精神疾病,特别是治疗耐药性抑郁症.
- 慢性休胺使用与泌尿毒性有关,这引发了治疗用途的安全问题.
研究的目的:
- 系统地审查使用胺治疗精神疾病的研究中的泌尿病学发现.
- 评估重复胺治疗对尿道,膀或脏健康的安全性.
主要方法:
- 临床试验和观察性研究的系统审查至2024年4月4日.
- 包括的研究评估了成年人因精神疾病接受胺治疗的尿道,膀或症状.
- 分析了27项研究,主要涉及抑郁症.
主要成果:
- 在0%-24.5%的患者中报告了泌尿系统症状,一般为轻度至中度.
- 持续的结果测量显示,尿路参数或症状没有显著变化.
- 只有15%的研究具有低偏差风险;大多数缺乏长期评估或系统的泌尿器科监测.
结论:
- 目前有限的数据表明,对精神疾病的胺治疗与泌尿器官症状的风险增加无关.
- 需要进行进一步的长期研究,以确定治疗性胺的泌尿安全性.
相关概念视频
Electroconvulsive Therapy
203
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
203
Psychosis: Goals of Pharmacotherapy
214
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
214
Chronic Kidney Disease II: Clinical Manifestations
104
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
104
Parenteral Anesthetics: Overview
205
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
205
Sedatives and Hypnotics Drugs: Miscellaneous Agents
247
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
247
Psychosis and Antipsychotic Drugs: Overview
469
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
469


